Aurobindo Pharma Ltd

Aurobindo Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aurobindo Pharma Ltd

₹ 1,191 0.87%
27 May - close price
aurobindo.com BSE: 524804 NSE: AUROPHARMA
About

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)

Key Points

Leading Pharmaceutical Company
The company is India’s 2nd-largest listed pharma company based on revenue & the largest generics company in the US. It is ranked among the top 10 generic companies in 8 European countries. [1]

Website BSE NSE
  • Market Cap ₹ 69,889 Cr.
  • Current Price ₹ 1,191
  • High / Low ₹ 1,593 / 994
  • Stock P/E 40.0
  • Book Value ₹ 350
  • Dividend Yield 0.38 %
  • ROCE 10.8 %
  • ROE 8.68 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 3.40 times its book value
  • The company has delivered a poor sales growth of -3.95% over past five years.
  • Company has a low return on equity of 8.69% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE 500 BSE Healthcare BSE 200 Nifty 500 BSE MidCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
2,887 1,742 1,948 2,361 2,406 2,391 2,669 2,692 2,894 2,460 2,825 2,917 2,732
2,380 1,529 1,680 1,917 1,830 1,968 2,124 2,210 2,119 1,961 2,104 2,203 2,135
Operating Profit 507 213 268 444 576 422 545 482 775 499 721 713 597
OPM % 18% 12% 14% 19% 24% 18% 20% 18% 27% 20% 26% 24% 22%
339 38 36 54 326 113 103 331 123 65 123 54 114
Interest 5 6 12 25 32 32 37 61 53 51 52 66 61
Depreciation 101 56 61 60 67 60 66 64 65 67 68 68 94
Profit before tax 740 189 231 413 804 444 546 687 780 446 724 633 556
Tax % -8% 35% 29% 28% 20% 24% 24% 9% 26% 26% 26% 25% 27%
802 122 165 299 645 336 416 624 579 329 538 472 408
EPS in Rs 13.69 2.08 2.81 5.10 11.01 5.74 7.10 10.65 9.88 5.62 9.17 8.06 6.97
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
7,108 8,069 9,158 9,607 10,270 12,258 13,371 15,824 11,287 8,457 10,646 10,933
5,187 5,816 6,705 7,215 7,600 9,838 10,670 11,704 9,783 6,952 8,422 8,376
Operating Profit 1,922 2,253 2,453 2,392 2,670 2,420 2,700 4,120 1,504 1,505 2,224 2,558
OPM % 27% 28% 27% 25% 26% 20% 20% 26% 13% 18% 21% 23%
73 65 187 118 81 189 386 590 565 429 670 328
Interest 289 132 229 45 53 231 243 29 17 75 183 230
Depreciation 186 245 263 286 355 413 473 488 415 243 255 297
Profit before tax 1,519 1,940 2,148 2,179 2,343 1,965 2,370 4,193 1,637 1,616 2,457 2,358
Tax % 23% 22% 24% 22% 23% 22% 21% 26% 11% 24% 20% 26%
1,172 1,516 1,627 1,707 1,813 1,530 1,877 3,113 1,455 1,227 1,954 1,747
EPS in Rs 20.11 25.96 27.80 29.13 30.94 26.11 32.03 53.13 24.83 20.94 33.35 29.81
Dividend Payout % 7% 9% 9% 9% 8% 10% 9% 8% 36% 36% 13% 0%
Compounded Sales Growth
10 Years: 3%
5 Years: -4%
3 Years: -1%
TTM: 3%
Compounded Profit Growth
10 Years: 1%
5 Years: -1%
3 Years: 4%
TTM: -11%
Stock Price CAGR
10 Years: 6%
5 Years: 11%
3 Years: 31%
1 Year: 0%
Return on Equity
10 Years: 14%
5 Years: 11%
3 Years: 9%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 29 29 59 59 59 59 59 59 59 59 59 58
Reserves 3,983 5,330 6,807 8,378 9,924 11,292 12,994 15,866 17,059 17,975 19,664 20,476
2,925 3,285 4,165 3,054 3,719 4,520 3,741 4,042 1,895 4,203 2,861 4,647
1,638 1,582 1,534 1,533 2,092 2,270 2,770 3,222 2,589 2,822 2,570 2,332
Total Liabilities 8,576 10,226 12,566 13,023 15,794 18,141 19,564 23,189 21,601 25,059 25,154 27,513
1,938 2,190 2,568 3,212 3,393 4,150 4,418 4,472 3,586 3,688 2,419 2,337
CWIP 204 227 742 907 1,144 789 815 735 225 239 133 88
Investments 873 1,013 1,183 1,682 1,968 2,339 2,527 5,010 6,584 8,105 13,393 15,210
5,561 6,796 8,072 7,222 9,289 10,863 11,804 12,972 11,206 13,027 9,209 9,879
Total Assets 8,576 10,226 12,566 13,023 15,794 18,141 19,564 23,189 21,601 25,059 25,154 27,513

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
328 590 1,185 2,457 922 530 2,201 2,995 3,727 1,816 1,715 1,646
-401 -624 -1,390 -1,542 -991 -1,301 -948 -2,650 -1,615 -3,230 -152 -2,066
-31 35 515 -1,329 440 599 -1,255 -28 -2,448 1,719 -1,837 616
Net Cash Flow -105 1 310 -414 371 -171 -1 316 -335 306 -274 196

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 153 168 175 143 159 156 158 137 128 197 129 140
Inventory Days 179 207 207 191 273 235 242 244 210 335 148 154
Days Payable 130 111 109 96 130 109 107 104 130 179 112 116
Cash Conversion Cycle 202 264 273 239 301 282 293 277 208 353 166 177
Working Capital Days 182 208 220 197 236 242 234 208 241 305 162 174
ROCE % 29% 27% 24% 20% 19% 15% 16% 23% 9% 8% 12% 11%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
51.83% 51.84% 51.84% 51.84% 51.84% 51.84% 51.84% 51.84% 51.80% 51.82% 51.82% 51.82%
20.71% 21.41% 22.31% 23.03% 24.12% 22.45% 20.72% 18.01% 16.73% 16.59% 16.29% 15.33%
17.30% 16.56% 14.90% 15.09% 15.73% 18.29% 20.60% 23.28% 24.77% 25.14% 25.21% 26.23%
10.15% 10.20% 10.96% 10.06% 8.31% 7.43% 6.85% 6.87% 6.69% 6.45% 6.67% 6.61%
No. of Shareholders 3,59,6843,58,4593,69,8283,43,6172,93,2142,59,6382,41,9442,44,5752,38,6222,48,4882,57,9622,69,323

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls